Stocktoria
PLUS THERAPEUTICS, INC. PSTV
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2000-08-09
PLUS THERAPEUTICS, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $5.2M | $5.8M | $4.9M | — | — |
| R&D expense | $8.4M | $10.6M | $9.7M | $9.7M | — |
| Operating income | -$15.3M | -$14.7M | -$13.3M | -$19.7M | -$12.5M |
| Interest expense | — | — | $395,000 | $711,000 | $932,000 |
| Income tax | $0 | $0 | $0 | $0 | $0 |
| Net income | -$22.4M | -$13.0M | -$13.3M | -$20.3M | -$13.4M |
| EPS (diluted) | $-0.29 | $-2.34 | $-4.24 | $-11.58 | $-1.11 |
| Operating cash flow | -$20.8M | -$10.6M | -$12.9M | -$13.0M | -$10.3M |
| Free cash flow | -$20.8M | -$10.7M | -$13.0M | — | — |
| Cash & equivalents | $4.3M | $76,000 | $8.6M | $18.1M | $18.4M |
| Total assets | $16.3M | $6.6M | $11.4M | $23.9M | $22.0M |
| Total liabilities | $12.3M | $15.6M | $12.7M | $17.4M | $11.1M |
| Shareholders' equity | $4.0M | -$8.9M | -$1.3M | $6.4M | $10.8M |
Source: SEC EDGAR filings · CIK 0001095981 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.